Functional health and well-being of relatively young women with peripheral arterial disease is decreased but stable after diagnosis  by Bloemenkamp, Daisy G.M et al.
Functional health and well-being of relatively
young women with peripheral arterial disease is
decreased but stable after diagnosis
Daisy G. M. Bloemenkamp, MD, PhD,a,b Willem P. Th. M. Mali, MD, PhD,b Bea C. Tanis, MD,d
Maurice A. A. J. van den Bosch, MD, PhD,b Jeanet M. Kemmeren, PhD,a Ale Algra, MD, PhD,a,c and
Yolanda van der Graaf, MD, PhD,a Utrecht and Leiden, The Netherlands
Objective: This study was undertaken to investigate the extent to which health-related quality of life (HQOL) is reduced
in young women with peripheral arterial disease (PAD) compared with age-matched and gender-matched control
subjects. Moreover, potential determinants of HQOL in young women with PAD were studied, ie, traditional
cardiovascular risk factors, location of stenosis and time since diagnosis.
Methods: This was a population-based case-control study.
Subjects were 208 young (<50 years) women with PAD diagnosed at angiography and 471 population-based age-
matched and gender-matched control subjects. All participants completed the RAND-36 questionnaire, which produces
a HQOL profile. The questionnaire contains 36 items that assess 8 domains of HQOL. Each domain is given a mean score
ranging from 0 to 100, with higher scores indicative of better quality of life.
Results: PAD had a deleterious effect on HQOL in young women. Ability to deal with the physical requirements of daily
life was affected, and physical capabilities limited activity to a considerable extent. Mean differences observed for 2
domains, ie, Physical functioning and Role-physical, were 25.1 (95% confidence interval [CI], 28.8,21.4) and
22.5 (95% CI, 28.9,16.0).
Within the group of young women with PAD, HQOL did not depend on age, smoking, hypercholesterolemia, or
education. However, women with hyperglycemia, hypertension, or increased body mass index scored lower on 1 or more
domains of RAND-36. Location of stenosis was also related to HQOL; patients with more proximal stenosis scored
slightly higher on the domain Physical functioning, compared with women with more distal stenosis. Time (0-10 years)
between diagnosis (1990-1999) and when RAND-36 was filled out (2000) is related to score on the Mental health
domain; score increases over time. Scores on the other 7 domains of HQOL showed no significant relation to duration
of disease.
Conclusion: Quality of life in young women with PAD was statistically significant diminished for all domains of RAND-36
in comparison with HQOL in healthy age-matched control subjects. HQOL of patients with recently diagnosed PAD is
comparable to that of patients in whom the diagnosis was made several years previously. Effective therapy might stabilize,
albeit not improve, quality of life in this specific patient population. (J Vasc Surg 2003;38:104-10.)
Health-related quality of life (HQOL) measurements
are obtained to determine the influence of disease on
overall patient functioning and well-being. HQOL mea-
surements can also be used to evaluate treatment or to
assess the effect of disease on daily life.1 We investigated the
extent to which HQOL is reduced in young women with
peripheral arterial disease (PAD). The reasons for our in-
terest in this specific patient population are several.
First, most epidemiologic studies of cardiovascular dis-
eases have focused on coronary artery disease (CAD), be-
cause of high morbidity and mortality associated with this
condition. Research on other manifestations of atheroscle-
rosis, eg, PAD, has been limited. Apparently study of PAD
is not so attractive, probably because it is considered a
chronic disease of old age and is associated with gradual
decline.2 However, there is conclusive evidence that pa-
tients with claudication are at greatly increased risk for
major cardiovascular events. The relative risk for fatal or
nonfatal myocardial infarction or stroke is two to three
times higher in patients with claudication compared with
those without this complication.3-5 Mortality from all
causes is also increased twofold or threefold.3-5 These seri-
ous medical complications and consequences of PAD easily
justify the need for more scientific interest in this group of
patients.
Second, although the prevalence of PAD in young
(50 years) persons is lower than in older persons, prema-
ture PAD, diagnosed before age 50 years, is not rare.6
Young adults make up 1% to 7% of all patients with vascular
disease.7,8 Manifestation of PAD in young patients com-
monly involves the aortoiliac segment of the vascular tree,
rather than more distally localized segments that are fre-
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quently affected in older patients.8 Another striking obser-
vation is that this typical picture, characterized by local
obstruction in the distal aorta or iliac arteries without
defects in other arteries, is more often observed in women
than in men.9
Inasmuch as PAD is not uncommon in younger per-
sons and because involvement of the more proximal arteries
is noted more frequently in women than in men, we studied
the effect of this disease on HQOL in young women. Our
interest was focused on the extent to which HQOL is
reduced in this specific patient population compared with
age-matched and gender-matched control subjects. More-
over, we studied some potential determinants of quality of
life in young women with PAD. In addition to traditional
cardiovascular risk factors, location of stenosis and time
since diagnosis were considered potential determinants of
HQOL.
METHODS
Study design. Analyses were performed within the
framework of the Risk of Arterial Thrombosis in relation to
Oral Contraceptives (RATIO) study. This multicenter,
population-based case-control study was conducted to in-
vestigate the relation between vascular disease (stroke,
myocardial infarction, PAD) and oral contraceptive use
among young women referred between January 1990 and
October 1995. In addition to the relation between oral
contraceptives and PAD, RATIO was designed to examine
other risk factors for PAD in young women. In the first
phase of RATIO, a standardized mailed questionnaire was
filled out by all patients and control subjects. The relation-
ships between oral contraceptive use and myocardial infarc-
tion, stroke, or PAD were reported separately.10-12
In a second phase of the study, all participants were
approached again and asked to donate blood samples and
to fill out the RAND-36-Item Health Survey 1.0 (RAND-
36) questionnaire. In addition, the group of patients with
PAD was enlarged with women who were referred between
November 1995 and December 1999. Patients not in-
cluded in the first phase of RATIO also received the first
questionnaire about cardiovascular risk factors and oral
contraceptive use. The study protocol was approved by the
ethics committees of all participating hospitals (see Ac-
knowledgment), and informed consent was given by all
participants.
Patients. Female patients were eligible if they had
been referred to one of the collaborating hospitals between
January 1, 1990, and December 31, 1999; had an angio-
graphically confirmed diagnosis of PAD; were between 18
and 49 years of age at referral; and gave informed consent.
PAD was considered if a patient had the typical symptom of
intermittent claudication, ie, cramping pain in the lower
legs during exercise, or had rest pain, nonhealing ulcer, or
gangrene. Intra-arterial angiography was performed in all
patients. A stenotic lesion with more than 50% reduction of
the lumen in at least 1 major peripheral artery (distal
abdominal aorta; common, internal, or external iliac artery;
femoral artery; popliteal artery; anterior or posterior tibial
artery; peroneal artery) was considered diagnostic of PAD.
Of the 294 eligible patients with PAD, 24 could not be
located, despite extensive efforts. Of the 270 patients who
were successfully approached, 208 agreed to fill out the
RAND-36 questionnaire and to donate blood samples. A
little more than half of these patients (113) were referred
between January 1990 and October 1995 and had also
participated in the first phase of the RATIO study.
Control subjects. Control subjects were recruited by
random digit dialing (RDD); ie, random telephone num-
bers in The Netherlands were dialed, and eligible members
of the household (female sex; age, 18-49 years) were asked
to participate in the study.13,14 This method resulted in
selection of 925 control subjects who were approximately
the same age (5 strata of 1 year) as patients with PAD. In
the second phase, 643 of the 925 control subjects donated
blood samples. Subsequently, 471 of these 643 women
filled out RAND-36 and their data could therefore be
included in the analyses. Reasons most frequently listed for
not participating in the second phase of RATIO were lack
of time and fear of venipuncture.
Data collection. Between June 1, 1998, and May 1,
2000, all participants underwent blood pressure measure-
ment, donated nonfasting venous blood samples, and com-
pleted a questionnaire (RAND-36) about HQOL. Blood
pressure was measured semiautomatically (OmronM1;
OMRON Healthcare, Hamburg, Germany) at 1 point in
time. Serum or plasma samples were stored at80°C until
processed. Serum total cholesterol, high-density lipopro-
tein (HDL)–cholesterol, triglyceride, and glucose concen-
trations were measured with a clinical analyzer (Roche/
Hitachi 747, Mannheim, Germany). Data obtained from
the questionnaire included current medication use and
classic risk factors, including body mass index (BMI),
smoking history (current, former, never), and history of
hypercholesterolemia, as defined by use of cholesterol-
lowering medication or serum total cholesterol concentra-
tion 5.0 mmol/L or greater, diabetes mellitus, as defined
by use of glucose-lowering medication or nonfasting serum
glucose concentration 11.0 mmol/L or greater, or hyper-
tension, as defined by use of antihypertensive drugs or
systolic blood pressure 160 mm Hg or greater or diastolic
blood pressure 95 mm Hg or greater. Socioeconomic
status was defined as highest level of education attained, ie,
primary school, secondary school, or university.
Inasmuch as the manifestation of PAD in young pa-
tients commonly involves the aortoiliac segment of the
vascular tree, patients were classified in two groups.8 Based
on angiographic studies, the first group consisted of pa-
tients with at least one obstruction confined to arterial
segments above the inguinal ligament, ie, distal abdominal
aorta or common, internal, or external iliac artery. It is not
always possible to visualize the distal arteries in patients
with PAD; therefore patients with stenosis above and below
the inguinal ligament were also categorized in this first
group. The second group consisted of patients without any
obstruction above the inguinal ligament, which implies at
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least one obstruction in the femoral, popliteal, anterior or
posterior tibial, or peroneal artery.
HQOL of all participants was assessed between June 1,
1998, and May 1, 2000. As a result, the period between
diagnosis of PAD and assessment of HQOL varied among
patients. This variation was used to assess HQOL according
to time since PAD diagnosis. The year in which the diag-
nosis was made was used as a proxy for the duration of this
period. Index year was categorized in 5 subgroups: 1990-
1991, 1992-1993, 1994-1995, 1996-1997, and 1998-
1999; duration between diagnosis of PAD and assessment
of HQOL in the 5 subcategories decreased, respectively.
Health-related quality of life. The Dutch version of
RAND 36 was used to measure HQOL.1,15,16 The ques-
tionnaire contains 36 items that assess 8 domains of
HQOL:
Physical functioning, a 10-question scale that captures abil-
ity to deal with physical requirements of life, eg, attend-
ing to personal needs, walking, and flexibility
Social functioning, a 2-item scale that evaluates extent and
amount of time, if any, that physical health or emo-
tional problems interfered with family, friends, and
other social interactions during the most recent 4 weeks
Role-physical, a 4-item scale that evaluates extent to which
physical capabilities limit activity
Role-emotional, a 3-item scale that evaluates extent, if any,
to which emotional factors interfere with work or other
activities
Mental health, a 5-item scale that evaluates feelings, prin-
cipally of anxiety and depression
Vitality, a 4-item scale that evaluates feeling of pep, energy,
and fatigue
Bodily pain, a 2-item scale that evaluates perceived amount
of pain experienced during the most recent 4 weeks and
extent to which that pain interfered with normal work
activities
General health, a 5-item scale that evaluates general health
in terms of personal perception
The number of questions directed to each health con-
cept ranges from 2 for Social functioning and Bodily pain to
10 for Physical functioning, and the number of response
options per question ranges from 2 (no, yes) to 6 (none,
very mild, mild, moderate, severe, very severe). Each
HQOL domain is given a mean score ranging from 0 to
100, with higher scores indicative of better quality of life.
Statistical analysis. Mean values or proportions for
cardiovascular risk factors were calculated separately for
patients and control subjects. Linear regression models
were used to calculate the difference of mean values of the
8 domains of HQOL between patients with PAD and
control subjects. Adjustment was made for age and educa-
tion (0, low; 1, intermediate; 2, high).
Within the group of patients with PAD the relationship
between several patient characteristics and time since diag-
nosis, and the 8 domains of HQOL was quantified with
univariate linear regression analysis. Regression coefficients
() may be interpreted as mean difference in an HQOL
domain per unit increase of the characteristic studied.
RESULTS
Characteristics of 208 patients with PAD and 471
control subjects are shown in Table I. Traditional risk
factors for atherosclerosis were more prevalent in patients
than in control subjects.
Differences between patients and control subjects in
various domains of RAND-36 are presented in Table II.
Patients with PAD scored worse than control subjects did
in all 8 aspects of HQOL. Adjusted for age and education,
differences in mean values between patients and control
subjects were statistically significant. The largest differences
were observed for the domains of Physical functioning and
Role-physical: 25.1 (95% confidence interval [CI],
28.8,21.4) and 22.5 [95% CI, 28.9,16.0), re-
spectively.
Difference (95% CI) of mean scores for the 8 domains
of RAND-36 among patients with PAD grouped according
to dichotomous variables, including hypercholesterolemia
(no/yes), hyperglycemia (no/yes), hypertension (no/yes),
Table I. Characteristics of patients with PAD and control
subjects
Characteristic
Patients
(n  208)
Control
subjects
(n  471)
n % n %
Age (y) (mean  SD) 48.2  7.0 45.4  8.1
BMI (kg/m2) (mean  SD) 26.3  5.8 25.0  4.3
Smoking
Current 121 60 150 32
Former 74 36 152 33
Never 9 5 160 34
History
Hypercholesterolemia* 178 88 276 60
Diabetes mellitus† 28 14 3 1
Hypertension‡ 121 61 112 24
Education
Primary school or less 38 19 40 9
Secondary school 142 72 311 6
Higher education or university 17 9 117 25
Location of stenosis
Above inguinal ligament 78 38 –
Below inguinal ligament 130 62
Year of diagnosis
1990-1991 44 21
1992-1993 31 15
1994-1995 46 22
1996-1997 49 24
1998-1999 38 18
PAD, Peripheral artery disease; BMI, body mass index; SD, standard devia-
tion.
*Positive history of hypercholesterolemia defined as use of lipid-lowering
medication and/or cholesterol plasma concentration 5.0 mmol/L.
†Positive history of diabetes defined as use of blood glucose-lowering
medication and/or nonfasting glucose plasma concentration 11.0
mmol/L.
‡Positive history of hypertension defined as use of antihypertensive medica-
tion, and/or systolic BP  160 mm Hg and/or diastolic BP  90 mm Hg.
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and location of stenosis above inguinal ligament (no/yes),
are shown in Table III. In addition, strength of a potential
trend between HQOL and the continuous variables of age
(years) and BMI (kg/m2) or the categorical variables of
smoking (never, former, current), education (low, interme-
diate, high), and index year category (0, 1, 2, 3, 4) is shown
in Table III. HQOL of patient with hypercholesterolemia
does not significantly differ from that of patients with
normal cholesterol concentration. Further, age, smoking,
and education are not related in linear fashion to any of the
8 domains of RAND-36. Patients with hyperglycemia,
however, have a largely reduced score for 4 domains of
RAND-36: Physical functioning, Role-physical, Role-emo-
tional, and General health. Also, hypertension is related to
a statistically significant lower score for the domain General
health, although the decrease is small.
Stenosis above the inguinal ligament was noted in 38%
of patients. Patients with proximal stenosis (above the
inguinal ligament) scored a little higher for all domains of
RAND-36, compared with patients with more distal arte-
rial stenosis. However, the differences were not statistically
significant except for the domain Physical functioning (8.9
[95% CI, 0.9, 16.9). Increased BMI is associated with a
small decrease in Physical functioning. The distribution of
vascular risk factors over these two groups showed no
statistically significant differences, except for smoking. Sev-
enty-three percent of patients with proximal PAD were
current smokers, and 27% were former smokers, compared
Table II. Health dimensions of RAND 36-Item Health Survey measured in women with PAD and in population-based
female control subjects
RAND-36 domain
Response in patients with
PAD/control subjects
Patients with
PAD mean
(SD)
Control mean
(sd)
Difference
of means* 95% CI
Physical functioning 200/456 60.7 (28.1) 86.4 (17.3) 25.1 28.8,21.4
Social functioning 201/468 72.0 (26.7) 82.1 (22.7) 10.2 14.3, 6.0
Role-physical 187/451 61.4 (42.3) 83.0 (33.1) 22.5 28.9,16.0
Role-emotional 186/447 72.2 (40.3) 84.6 (32.2) 13.5 19.7, 7.2
Mental health 198/464 69.2 (19.7) 74.8 (16.2) 5.5 8.5, 2.5
Vitality 198/464 54.5 (21.6) 63.5 (19.1) 8.7 12.2, 5.2
Bodily pain 203/466 68.7 (27.0) 80.6 (22.1) 11.4 15.5, 7.3
General health 199/461 56.8 (18.2) 68.7 (14.8) 11.9 14.7, 9.1
PAD, Peripheral artery disease; SD, standard deviation; CI, confidence interval.
*Differences in mean score for different RAND-36 domains adjusted for age and socioeconomic status.
Table III. Relation between vascular risk factors and 8 health dimensions of RAND 36-Item Health Survey in women
with PAD
PF SF RP RE MH VT BP GH
Age (y) NS NS NS NS NS NS NS NS
BMI (kg/m2) 0.7 NS NS NS NS NS NS NS
(1.6, 0.3)
Smoking (never, former,
current)
NS NS NS NS NS NS NS NS
Hypercholesterolemia
(no, yes)
NS NS NS NS NS NS NS NS
Hyperglycemia (no, yes) 16.0 NS 18.9 16.9 NS NS NS 9.5
(27.1, 5.0) (36.0, 1.7) (33.2, 0.6) (16.6, 2.3)
Hypertension (no, yes) NS NS NS NS NS NS NS 5.6
(10.8, 0.4)
Education (low, middle,
high)
NS NS NS NS NS NS NS NS
Stenosis in distal aorta
(no, yes)
8.9 NS NS NS NS NS NS NS
Index year* (0, 1, 2, 3, 4)† NS NS NS NS 2.3 NS NS NS
(4.3, 0.3)
Numbers in parentheses represent 95% confidence interval.
PF, Physical functioning; SF, social functioning; RP, role-physical; RE, role-emotional; MH, mental health; VT, vitality; BP, bodily pain; GH, general health;
BMI, body mass index; NS, not significant.
*Index year is the year in which PAD was first diagnosed at angiography.
†1990-1991, 1992-1993, 1994-1995, 1996-1997, 1998-1999, respectively.
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with 51% and 42%, respectively, of patients with distal PAD
(P  .02).
The year in which PAD was first diagnosed was divided
into 5 subcategories; the number of patients in each cate-
gory varied between 31 (15%) and 49 (24%).
A higher index year category, ie, shorter time between
diagnosis and time when when RAND-36 was filled out,
was related to a small decrease in score for the domain
Mental health; however, scores for the other 7 domains of
HQOL showed no relation to duration of this interval.
DISCUSSION
Young women with PAD scored lower than age-
matched healthy women on all 8 domains of HQOL as-
sessed with RAND-36. Differences for Physical functioning
and Role-physical, two domains that express ability to deal
with physical requirements of daily life and extent to which
physical capabilities limit activity, were largest. Among
patients with PAD, location of stenosis above or below the
inguinal ligament did not have a pronounced effect on
HQOL, except for scores for Physical functioning, which
was in favor of patients with proximal stenosis.
There was no convincing relationship between year in
which PAD was first diagnosed and HQOL for most do-
mains of RAND-36. Despite increasing awareness of the
disease and availability of various treatment strategies,
HQOL in young women with PAD is decreased at diagno-
sis and remains decreased in the years thereafter. One
exception might be in the domain Mental health; feelings
of anxiety and depression seem to decrease after the diag-
nosis of PAD. Score for Mental health was higher in pa-
tients with a long-time diagnosis compared with patients
with a recent diagnosis. The general stabilization of HQOL
in young women with PAD might be due to availability of
treatment that stabilizes the effect of this chronic disease on
the patient’s life. However, it might also be interpreted
more negatively as the result of treatment that fails to
improve quality of life in these patients.
Optional medical and surgical therapies for PAD have
been extensively reviewed in a consensus publication.17
Shortly thereafter, a review that focussed on risk-factor
modification and on strategies for symptomatic relief in
patients with PAD was published.18 The question is
whether availability of the many treatment possibilities
implies that quality of life of patients with PAD is improved
once the diagnosis is made. To the best of our knowledge,
comparable, pragmatic results from long-term follow-up
studies of HQOL in patients with PAD are not available.
The present study did not have a follow-up design either,
but it may be considered as a combination of several cross-
sectional studies in which the interval between diagnosis
and assessment of HQOL differs. Therefore it is possible to
study HQOL in patients with PAD that was diagnosed
within subsequent time periods. If treatment, regardless of
type, had been effectively applied over the last 10 years,
HQOL of patients with PAD would be expected to im-
prove or at least stabilize over the years after the diagnosis
was made. Inasmuch as we found no pronounced relation-
ship between year when the diagnosis was made and results
on RAND-36, it might be concluded that permanent im-
provement in HQOL in young women with PAD is un-
likely. Despite growing knowledge about the causes of
PAD, the increasing amount of diagnostic tests available to
visualize the disease, and advanced therapy strategies, qual-
ity of life in patients with PAD seems to remain suboptimal
after the diagnosis has been made. Repeated measurements
in patients or control subjects were not available because of
the cross-sectional design of the study. Therefore changes
in HQOL within a certain patient over time could not be
studied.
Although RAND-36 is not specific to PAD, it is rec-
ommended by the TransAtlantic Inter-Society Consensus
(TASC) to measure baseline generic health status in pa-
tients with PAD.17 Previously it has been used by authors
who studied quality of life in patients with PAD.19-23 Most
patients included in these studies were men older than 50
years (Table IV). Unanimously, all authors agree that
HQOL is decreased in patients with PAD. Therefore the
results of the present study are not exceptional, because
they agree with the results of former studies. However,
because only young women were included, our results add
to existing knowledge.
The response rate within the control group was lower
than that in the patients. The reason for this was largely
practical, owing to lack of time to fill out RAND-36 or fear
of venipuncture. However, it is possible that, because of the
nonresponding individuals, a selection of the most fit and
healthy control subjects occurred, which might have led to
exaggerated differences in the 8 domains of HQOL be-
tween patients and control subjects. To test for this unfa-
vorable option, we performed two additional analyses. First
we compared the group of individuals who were included
with those who refused to participate in the second phase of
our study. The distribution of vascular risk factors, eg,
hypertension, hypercholesterolemia, diabetes, and smok-
ing, did not differ between included and not included
women. Second, the Dutch version of RAND-36 has been
validated in a group of 1063 persons with ages 18 to 89
years (mean, 44 years), 65% of whom are women.16 Selec-
tions of this validation population are provided, and can be
used as a reference population. We compared scores for the
patients with PAD with scores for a reference population
that consisted of 180 individuals, with age between 45 and
54 years. Women with PAD scored worse than did healthy
individuals on all domains of RAND-36. Thus, if another
group of subjects is used as reference, the results do not
change essentially.
Patients in the present study were included if they had
intermittent claudication and significant stenosis in one of
the main peripheral arteries as documented at angiography.
Control subjects were selected from the general population
and therefore did not undergo angiography. To exclude
symptomatic PAD, we excluded all control subjects with
complaints of intermittent claudication or earlier treatment
for PAD. It is possible that certain control subjects have
asymptomatic PAD, as evidenced by ankle-brachial index
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(ABI) less than 0.90. We did not measure ABI in the
control group and therefore could not exclude these indi-
viduals. If the control group contains a certain number of
patients with asymptomatic PAD, this could have decreased
HQOL in the control group. Therefore the “real” differ-
ence in HQOL between patients with PAD and healthy
control subjects could be slightly larger.
Mean age of control subjects was lower than that of
patients with PAD, and level of education, as a proxy for
socioeconomic status, was higher in control subjects. These
potential confounding variables could have distorted the
results, because they also are related to quality of life.
Therefore the differences between patients and control
subjects were adjusted for these two variables. The differ-
ences were not adjusted for smoking, diabetes, hypercho-
lesterolemia, or hypertension, because these vascular risk
factors are considered part of the disease entity PAD. To
adjust for these variables would have led to overadjustment
and have given a false interpretation of the data.
In comparison of the different subgroups (based on
year of diagnosis) of patients with PAD, it was not necessary
to adjust mean differences, because no relation between
age, education, and HQOL was found within this homo-
geneous patient population.
In conclusion, PAD has a large effect on both physical
and emotional functioning of patients. Despite increasing
awareness on PAD, the HQOL in young women with PAD
is drastically impaired for all 8 domains of RAND-36. Once
the diagnosis has been made, it seems that quality of life
neither improves nor deteriorates. Use of advanced treat-
ment strategies might be considered as the cause of this
stabilization of quality of life in patients with this chronic
disease. However, quality of life of patients with PAD
remains suboptimal compared with that of healthy persons.
Therefore this group of patients needs more of our atten-
tion. By unraveling the cause of this chronic disease to
prevent it or by improving methods to treat PAD, it is
hoped that quality of life of affected patients will be im-
proved in the future.
We thank the five participating medical centers: Uni-
versity Medical Center Utrecht (W. P. Th. M. Mali, B. C.
Eikelboom), Academic Medical Center Amsterdam
(M. J. H. M. Jacobs, J. A. Reekers), Leiden University
Medical Center (J. H. van Bockel, E. van der Linden),
Academic Hospital Nijmegen (J. A. van der Vliet, F. M. J.
Heijstraten), Slingeland Ziekenhuis Doetinchem
Table IV. Details of previous studies that describe HQOL in patients with PAD, including present study
Pell19
Bosch and
Hunink21 Chetter et al22 Bartman et al23 Hicken et al23 Present study
Year of
publication
1995 1996 1997 1998 2000 2003
Objective To examine effect
of claudication
on HQOL
To assess
relationship
between
descriptive and
valuational QOL
measures in
patients with
intermittent
claudication
To determine
effect of
increasing lower
limb ischemia
on HQOL in
patients with
mild, moderate,
and severe
claudication and
inpatients with
rest pain and
tissue loss
To examine
relationship
between health
status and health
utility measures in
older patients with
claudication
To measure QOL
in patients with
claudication
To examine
HQOL in
young women
with PAD
Number of
patients
201 76 235 34 96 208
Male patients
(%)
63 70 61 95 68 0
M:F ratio 123:74 53:23 144:91 32:2 65:31 0:208
Mean age (y) 64 57 68 71 66 48
Control
group
Population
sample given
normal values
152 age-matched
and gender-
matched healthy
individuals from
general
population
– Population sample
of men aged 65
years or older
Population sample
given normal
values
471 age-matched
and gender-
matched
healthy
individuals
from general
population
Questionnaire
used
Medical Outcome
Study, short
Form-36
RAND 36-Item
Health Survey
Medical Outcome
Study, Short
Form-36
Medical Outcome
Study, Short
Form-36
RAND 36-Item
Health Survey
HQOL, Health-related quality of life; QOL, quality of life; PAD, peripheral artery disease.
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(J. G. J. M. van Iersel, J. Seegers, J. H. Spithoven). We also
thank all of the women who participated in this study.
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